Cardiovascular Disease Doctors in Willoughby, OH Accepting Medicare

5 Cardiovascular Disease doctors found. Showing 1 - 5

Kamal Sodi Riad, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2550 Som Center Road, Willoughby, OH 44094 Phone: 440-943-2500    Fax: 440-516-8666

Dr. Mohamed A Atassi, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 36100 Euclid Ave, Suite 120, Willoughby, OH 44094 Phone: 440-951-8360    Fax: 440-951-9408

Helge U. Simon, M.D Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 36060 Euclid Ave Ste 107, Willoughby, OH 44094 Phone: 440-269-8346    Fax: 440-975-5763

Dr. Timothy P Doyle, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 36100 Euclid Ave, Suite 120, Willoughby, OH 44094 Phone: 440-951-8360    Fax: 440-951-9408

Dr. John A Samsa, DO Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 36100 Euclid Ave, Suite 120, Willoughby, OH 44094 Phone: 440-951-8360    Fax: 440-951-9408

News Archive

CtIP protein plays a critical role in DNA repair

La Jolla, CA-In order to preserve our DNA, cells have developed an intricate system for monitoring and repairing DNA damage. Yet precisely how the initial damage signal is converted into a repair response remains unclear. Researchers at the Salk Institute for Biological Studies have now solved a crucial piece of the complex puzzle.

New prostate cancer metastasis prediction method

Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.

Center for LAM Research and Clinical Care at BWH to conduct phase I combination drug trial

The Center for LAM Research and Clinical Care at Brigham and Women's Hospital (BWH) has been awarded a $1 million plus, four-year grant from the U.S. Department of Defense Office of the Congressionally Directed Medical Research Programs to fund their work on lymphangioleiomyomatosis.

PMSI, Progressive Medical collaborate to deliver comprehensive workers' compensation pharmacy benefit management services

Progressive Medical and PMSI announced today that the two companies have entered into a definitive agreement to merge. The transaction is expected to close in the fourth quarter subject to receipt of regulatory clearance. The combined company, which will be led by Executive Chairman Eileen Auen from PMSI and Co-CEOs Emry Sisson and Tommy Young from Progressive Medical, will deliver comprehensive workers' compensation pharmacy benefit management services including end-to-end pharmacy, ancillary and settlement solutions.

Combined point-of-care nucleic acid and antibody testing increases COVID-19 detection

A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the University of Cambridge showed that this approach was superior to virus detection alone for diagnosing COVID-19 disease.

Read more Medical News

› Verified 3 days ago